This is Google's cache of It is a snapshot of the page as it appeared on Jun 24, 2014 07:09:10 GMT. The current page could have changed in the meantime. Learn more
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Text-only version


The BAPKPD Advisory Committee 

Terrence F. Blaschke, MD, is Senior Program Officer in Clinical Pharmacology at the Bill and Melinda Gates Foundation, Professor of Medicine and Molecular Pharmacology (Active Emeritus) at Stanford University, Adjunct Professor of Biopharmaceutical Sciences at UCSF and Adjunct Professor of Medicine at Indiana University. Dr. Blaschke received his medical degree from Columbia University and did his residency training in Internal Medicine at UCLA. Following fellowship training in Clinical Pharmacology at the University of California, San Francisco, he joined the faculty at Stanford University in 1974. Dr. Blaschke is a past president of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). He is the recipient of the Rawls-Palmer award, the Henry W Elliott award and the Oscar B. Hunter award from ASCPT. He has been a consultant and past Chair of the Generic Drugs Advisory Committee of the US FDA and a member of the Nonprescription Drugs Advisory Committee. He chaired the Drug Utilization Review Panel of USP from 1995-2000. He is also a consultant to a number of pharmaceutical firms and served on the Board of Directors of Therapeutic Discovery Corporation of Palo Alto, Crescendo Pharmaceuticals, in Mountain View, California and is now a director of DURECT Corporation in Cupertino, California. He was a member of the AIDS Clinical Trials Group (ACTG) at its inception, and has served as chair of the Pharmacology Committee and a member of the Executive Committee of the ACTG. Dr. Blaschke has over 170 original publications in peer reviewed journals and is an Associate Editor of the Annual Review of Pharmacology and Toxicology, and an Executive Editor of the British Journal of Clinical Pharmacology.

Amita Joshi, PhD, Sr Scientist/Sr Director, Head of Clinical Pharmacology, Genentech Research and Early Development

Lorin Roskos, PhD, Vice President, Global Head, Clinical Pharmacology & DMPK MedImmune LLC.
His group is responsible for systems pharmacology, translational pharmacokinetics and pharmacodynamics (PK-PD), pharmacometrics, bioanalytics including PK, immunogenicity and PD biomarker assays, and clinical sample and data management. The group supports MedImmune’s biopharmaceutical portfolio at all stages of R&D and for all therapeutic areas.

Lorin joined AstraZeneca/MedImmune in 2006. Previously, Lorin spent six years at Abgenix, as the head of pharmacokinetics and toxicology, and he has prior experience in pharmacokinetics and drug metabolism at Amgen and Eli Lilly, where he worked on the development of large and small molecule drugs. Lorin received a PhD in pharmaceutics from the University of Washington in 1994. He has published over 50 research articles, reviews, and book chapters on topics of PK-PD modeling, translational science, PD biomarker development, and immunogenicity testing.


Home - Job Listings - Upcoming Events - Other Local Events - Previous Events

Become a Member - Advisory Committee - Steering Committee - BAPKPD Contact